277. H. He, X.Y. Dong, L. Cao, Y.J. Sha, Y.P. Sun, S.S. Zhao, F.H. Meng*, Z.Y. Zhong*, Oral microbiota-regulating and inflammation-targeted polymersome-hydrogels for RNAi therapy of ulcerative colitis. Bioact Mater.2025,32-44.277.pdf

276. J.K. Guo, J.T. Huang, Z.L. Huang, D. Hu, H.J. Tan, Y. Wang, C. Deng*, X.L. Zhu*, Z.Y. Zhong*, Tumor vessel-adaptable adhesive and absorbable microspheres for sustainable transarterial chemoembolization therapy, Nature Commun. 2025, 166239.276.pdf

275. H.L. He, Y. Zheng, J.L. Ji, C.L. Ye, Y. Sun, Y.W. Peng, Y. Zhang*, Z.Y. Zhong*, Liposomal all-trans retinoic acid boosts anti-tumor immunity of radiotherapy via mitigating cancer stemness and remedying tumor microenvironment. J. Control. Release 2025, 385, 113995.275.pdf

274. J.K. Guo, H.J. Tan, W.T. Chen, Y. Wang, W.H. Lin, Z.Y. Zhong*, C. Deng*, Oncolytic microgels with regulated antibody release augment tumor immunotherapy, J. Control. Release 2025, 385, 114003.274.pdf

273. L.L. Liang, Z.Z. Zhai, W.H. Lin, L. Cao, H.L. Sun*, Z.Y. Zhong*, In situ generation of anti-leukemia vaccine by immunogenic dual-drug nanomedicine and polymersomal CpG nanoadjuvant, 2025, J. Colloid Interf. Sci, 699, 138144.273.pdf

272. Y. Zhao, L. Cao, S.S. Zhao, Z.Z. Zhai, X.L. Tang, L. Chen, H.L. Sun*, Z.Y. Zhong*, Polymersomal vincristine-PLK1 inhibitor boosts immunogenic cell death and antitumor immunity, Chem. Eng. J.  2025, 58, 164657.272.pdf

271. Q. Deng, S.J. Yue, F.T. You, Z.Z. Zhai, H.L. Sun*, L.L.Liang, C.M. Li, L. Yang *; Z.Y. Zhong*, Vincristine/Volasertib polymersome injection enables high-efficiency synergistic treatment of acute lymphoblastic leukemia, Acta Biomaterial.  2025, 200, 641-652.271.pdf

270. Z.W. Sun, J.Y. Wang, B.B. Guo, S.S. Zhao, S.Y. Miao, M.Y. Xia, Z.Y. Zhong*, F.H. Meng*, Nano-golden adjuvant-polymersomes empower tumor photothermal-immunotherapy, J. Control. Release 2025, 385, 113976.270.pdf

269. J. Cao, Y.J. Sha, M. Sun, L. Yang, R.K. Lv, L. Cao, Z.Y. Zhong*, F.H. Meng*, Sustained codelivery of heat shock protein peptide and rapamycin via nano-in-hydrogel induces immune tolerance in rheumatoid arthritis, J. Control. Release 2025, 383, 113842.269.pdf

268. P. Zhang, G.H. Cui, T.Z. Wang, X.F. Zhao, X.Y. Wang, R.N. Ye, T.H. Liu*, Y.R. Zheng*, Z.Y. ong*, In situ therapeutic vaccines for leukemia by chemo-nanoadjuvant therapy, J. Control. Release 2025, 383, 113851.268.pdf

267. Y. Shi, Y.P. Sun, S.S. Zhao, Z.W. Sun, M.Y. Xia, Z.Y. Zhong*, F.H. Meng*, Intranasal and Intravenous Sequential Administration of Survivin Peptide-CpG Nanovaccines Elicits Potent Immunity Toward Glioblastoma, Adv. Mater. 2025, e2420630.267.pdf

266. Z.Z. Zhai, C.M. Li, L. Chen, Y. Zhao, X.L.Tang, L. Cao, H.L. Sun*, Z.Y. Zhong*, Antibody-mediated ratiometric delivery of FLT3 and CDK4/6 dual inhibitors for targeted treatment of acute myeloid leukemia, J. Control. Release 2025, 384, 113934.266.pdf

265. S.S. Zhao, Z.W. Sun, M.Y. Xia, B.B. Guo, Y.Y. Qu, J.Y. Wang,  Z.Y. Zhong*, F.H. Meng*, Polymersome-enabled brain codelivery of STAT3 siRNA and CpG oligonucleotide boosts chemo-immunotherapy of malignant glioma, J. Control. Release 2025, 383, 113764.265.pdf

264. S.S. Zhao, Y.Y. Qu, Z.W. Sun, S. Zhang, M.Y. Xia, Y. Shi, J.Y. Wang, Y. Wang, Z.Y. Zhong*, F.H. Meng*, Glioblastoma Cell Lysate and Adjuvant Nanovaccines via Strategic Vaccination Completely Regress Established Murine Tumors, Adv. Healthc. Mater. 2025, 2500911.264.pdf

263. M.Y. Xia, X.Y. Zhao, Z.W. Sun,Y. Shi, W.H. Lin, Z.Y. Zhong*, F.H. Meng*, Brain-targeted polymersomes mediating RNAi of STAT3 sensitize glioblastoma to temozolomide and immunotherapy, J. Colloid Interf. Sci, 2025, 695, 137751.263.pdf

262. S.Q. Wang*, Z.Y. Zhong*, Integrating targeting and drug retention: A promising approach for cancer treatment, J. Control. Release 2025, 378, 247-249.262.pdf

261. R.N. Ye, Q.Z. Ren, L.M. Chang, S.Q. Zhang, C.C. Deng, L. Cao, M. Shi, Bo Lou, F.H. Meng, S. Du, K.Y. Ren, X.J Piao, C.C. Xu*, Z.Y. Zhong*. Administration route-commended concise organ-selective mRNA transfection (ACCOST) by cyclic disulfide-primed short polyethylenimine. Nano Today. 2025, 63, 102741.261.pdf

260. Y.Y. Qu, B.B. Guo, S.S. Zhao, J. Sun, J. Cao, M.Y. Xia, Z.Y. Zhong*, F.H. Meng*, Photothermal treatment of prostate tumor with micellar indocyanine greenandNapabucasintoco-ablatecancer cells and cancer stem cells. J. Control. Release 2025, 113704.260.pdf

259. J. Sun, J.T. Yang, J.K. Guo , L. Tao, B. Xu, G.L. Wang, F.H. Meng*, Z.Y. Zhong*, Dual-targeted alpha therapy mitigates prostate cancer and boosts immune checkpoint blockade therapy. J. Control. Release 2025 Apr 3: 113686.259.pdf

258. J.P. Shen, B. Xu, Y. Zheng, X.Y. Zhao, H.X. Qi, Y.G. Tang, W. h. Lin*, S.L. Li*, Z.Z. Zhong*, Near-Infrared Light-Responsive Immunomodulator Prodrugs Rejuvenating Immune Microenvironment for “Cold” Tumor Photoimmunotherapy. Angew. Chem. Int. Ed. 2025, e202425309.258.pdf

257. H.L. He, L. Liu, Y. Zheng, J.L. Ji, L. Cao, C.L. Ye, Y. Sun, Y. Zhang*, Z.Y. Zhong*, Tumor-Adhesive Chitosan-Derived Multi-Immune Agonist Unleashes Strong and Durable Anti-Cancer Immunity. Adv. Sci. 2025Feb25: e2414110.257.pdf

256. Y.Y. Zhang, X.F. Zhao, X. Wang, S.Y. Wang, Z.Z. Zhong*, C. Deng*, Polypeptide nanomicelles co-deliver PLK1 and BCL-2/xLinhibitorsfor synergetic therapy of brain tumor. Nano Today. 2025, 62, 102712.256.pdf

255.G.H. Cui, Y. Shao, J.Y. Wang, C.C. Xu*, J.P. Zhang*, Z.Y. Zhong*, Polymersome-mediated Cbl-b silencing activates T cells against solid tumors. Biomaterials Science. 2025.255.pdf

254. L. Yang, Y.J. Sha, Y.S. Wei, L.C Yin, Z.Y. Zhong*, F.H Meng*, Inflammation-targeted vesicles for co-delivery of methotrexate and TNF siRNA to alleviate collagen-induced arthritis. ActaBiomater. 2025,195, 338-349.254.pdf

253. X.Y. Zhao, J.P. Shen, H.X. Qi, J. Sun, B. Xu, L. Tao, W.H. Lin*, S.L. Li*, Z.Y. Zhong*, Thiophene engineering of near-infrared D-π-A nano-photosensitizers for enhanced multiple phototheranostics and inhibition of tumor metastasis. Journal of Colloid and Interface Science. 2025, 685, 291-303.253.pdf

252. Y. Sun, L. Liu, H.L. He, G.H. Cui, Y. Zheng, C.L. Ye, L.P. Qu, Y.P. Sun, J.L. Ji, T. Lammers, Y. Zhang*, Z. Y. Zhong*, Co-activating STING-TLR9 pathways promotes radiotherapy-induced cancer vaccination. J. Control. Release 2025, 379, 327-343.252.pdf

251. X.F. Zhao, Y.Y. Zhang, X. Wang, Z.M. Fu, Z.Y. Zhong*, Chao Deng*, Multivalent ionizable lipid-polypeptides for tumor-confined mRNA transfection. Bioactive Materials. 2025, 46, 423-433.251.pdf